Mayd receives 13 million euros

The medication delivery service has only been around since this year. The start-up now wants to expand to more cities.
Medication delivery service Mayd has raised €13 million in a funding round. Target Global led the funding round, and 468 Capital and Earlybird also invested in the new startup from McMakler founders Lukas Pieczonka and Hanno Heintzenberg. Also backing are Flixbus founders, Amorelie founder Lea-Sophie Cramer, Auto1 founder Hakan Koç and Aitme CEO Emmanuel Pallua Mayd.
The startup's name is an acronym for "Meds at your doorstep." Users can order medicines through an app and the delivery service will bring them within 30 minutes. "Almost everything is delivered instantly these days. Just not something you need urgently when you're sick and don't want to go out - so we thought this is where a delivery service makes sense," Pieczonka explained in the Techcrunch interview.
For now, the delivery service is only available in Berlin, where the newly founded startup is based. Pieczonka and Heintzenberg plan to expand to other German cities before the end of the year. When Germany introduces digital prescriptions next year, it should also be possible to order prescription drugs.

Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingRelated companies






FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?